Innovative Trial Designs in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Innovative Trial Designs in Brazil

Innovative Trial Designs in Brazil – Full Service CRO

Clinical research plays a crucial role in advancing medical knowledge and improving patient care. In recent years, Brazil has emerged as a leading force in adopting innovative trial designs that are transforming the field. By embracing cutting-edge methodologies, advanced technologies, and a collaborative approach, Brazil is paving the way for groundbreaking discoveries and enhancing healthcare practices.

This blog explores some of the innovative trial designs being implemented in Brazil, highlighting their impact on medical research, patient outcomes, and Brazil’s role in shaping the future of clinical trials.

Adaptive Clinical Trials

Adaptive clinical trials have gained significant traction in Brazil, allowing researchers to make real-time adjustments to study parameters based on emerging data. These trials offer flexibility in modifying factors such as sample size, treatment arms, and outcome measures while maintaining scientific rigor.

The adaptive approach optimizes efficiency, reduces costs, and shortens the overall trial duration. By adopting adaptive designs, Brazil fosters a dynamic research environment that enables more effective decision-making, accelerates drug development, and improves patient access to innovative treatments.

Basket and Umbrella Trials

Basket and umbrella trials are innovative trial designs embraced by Brazil to evaluate multiple treatments simultaneously. Basket trials assess the efficacy of a single treatment across different tumor types with shared molecular characteristics.

On the other hand, umbrella trials investigate various subtypes of a disease, testing different interventions tailored to specific patient characteristics. These designs streamline the evaluation of personalized medicine approaches, offer new possibilities for targeted therapies, and accelerate the identification of effective treatments in Brazil.

Pragmatic Trials

Pragmatic trials have gained momentum in Brazil, aiming to evaluate interventions in real-world clinical settings. These trials often have larger sample sizes and more inclusive eligibility criteria, providing insights into how treatments perform under routine practice conditions.

By embracing pragmatic trial designs, Brazil bridges the gap between research and clinical application, ensuring that evidence-based findings translate into meaningful improvements in patient care. Pragmatic trials enhance the relevance and generalizability of research outcomes, enabling better healthcare decision-making for the Brazilian population.

Innovative Trial Designs in Brazil

Innovative Trial Designs in Brazil

Cluster Randomized Trials

Cluster randomized trials are gaining popularity in Brazil, particularly in the evaluation of public health interventions. These trials involve randomizing groups or clusters of participants rather than individuals. Clusters can be hospitals, clinics, or communities.

This design is particularly valuable when evaluating interventions that affect an entire group or when individual randomization is not feasible. By employing cluster randomized trials, researchers in Brazil can assess the impact of interventions in real-world settings, considering the effects of social and environmental factors.

Virtual Trials and Remote Monitoring

Virtual trials and remote monitoring are transforming the landscape of clinical trials in Brazil. Leveraging technological advancements, these designs allow patients to participate in trials remotely, reducing geographical barriers, transportation issues, and the burden of frequent hospital visits.

Virtual trials and remote monitoring not only improve patient convenience and engagement but also enhance data collection and reduce the burden on healthcare infrastructure. Brazil’s embrace of virtual trials showcases its commitment to innovation and patient-centric research methodologies.

Conclusion

Brazil’s adoption of innovative trial designs is revolutionizing clinical research and driving advancements in healthcare. The incorporation of adaptive trials, basket and umbrella trials, pragmatic trials, cluster randomized trials, and virtual trials underscores Brazil’s dedication to improving patient outcomes through efficient and impactful research methodologies.

By leveraging these innovative approaches, Brazil is accelerating the translation of scientific discoveries into clinical practice, benefiting patients within the country and contributing to global medical advancements.

Through ongoing collaboration and a commitment to cutting-edge trial designs, Brazil is poised to play a significant role in shaping the future of clinical trials and making valuable contributions to medical research worldwide.

Innovative Trial Designs in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Innovative Trial Designs in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Innovative Trial Designs in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Innovative Trial Designs in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Innovative Trial Designs in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Innovative Trial Designs in Brazil

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Innovative Trial Designs in Brazil

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Innovative Trial Designs in Brazil

The Cohortias Team

Innovative Trial Designs in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Innovative Trial Designs in Brazil

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe